The stock of Motif Bio PLC (LON:MTFB) hit a new 52-week low and has GBX 31.54 target or 13.00% below today’s GBX 36.25 share price. The 5 months bearish chart indicates high risk for the GBX 39.52M company. The 1-year low was reported on Nov, 4 by Barchart.com. If the GBX 31.54 price target is reached, the company will be worth GBX 5.14 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 4.61% or GBX 1.75 on November 4, hitting GBX 36.25. About 317,060 shares traded hands or 162.63% up from the average. Motif Bio PLC (LON:MTFB) has declined 14.12% since April 6, 2016 and is downtrending. It has underperformed by 15.21% the S&P500.
Motif Bio PLC (LON:MTFB) Ratings Coverage
Out of 2 analysts covering Motif Bio Plc (LON:MTFB), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. GBX 140 is the highest target while GBX 110 is the lowest. The GBX 125 average target is 244.83% above today’s (GBX 36.25) stock price. Motif Bio Plc has been the topic of 40 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Northland Capital maintained the shares of MTFB in a report on Monday, March 14 with “Buy” rating. Northland Capital maintained Motif Bio PLC (LON:MTFB) rating on Wednesday, July 27. Northland Capital has “Buy” rating and GBX 140 price target. Northland Capital maintained the shares of MTFB in a report on Friday, August 26 with “Buy” rating. The company was maintained on Wednesday, March 23 by Northland Capital. As per Wednesday, November 25, the company rating was maintained by Beaufort Securities. The firm has “Speculative Buy” rating given on Monday, October 19 by Beaufort Securities. As per Tuesday, November 24, the company rating was maintained by Northland Capital. The stock has “Buy” rating given by Northland Capital on Wednesday, April 20. As per Wednesday, January 6, the company rating was maintained by Northland Capital. On Wednesday, November 11 the stock rating was maintained by Northland Capital with “Buy”.
Another recent and important Motif Bio PLC (LON:MTFB) news was published by Uk.Finance.Yahoo.com which published an article titled: “Motif Bio Plc (MTFB.L)” on April 02, 2015.
Motif Bio plc is a clinical-stage biopharmaceutical company. The company has a market cap of 39.52 million GBP. The Firm is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It currently has negative earnings. It operates in the development and commercialization of pharmaceutical formulations segment.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.